Chemical engineers from Johns Hopkins University have broken the "mucus barrier," engineering the first drug-delivery particles capable of passing through human mucus — regarded by many as nearly impenetrable — and carrying medication that could treat a range of diseases. Those conditions include lung cancer, cervical cancer and cystic fibrosis, the research noted in a presentation scheduled for the 236th National Meeting of the American Chemical Society.
- Breaking the mucus barrier unveils cancer cell secretsWed, 16 Mar 2011, 14:36:21 EDT
- Scientists identify gene for short-circuiting excess mucus in lung disease, common coldsMon, 14 Sep 2009, 18:15:42 EDT
- Novel drug offers hope for early intervention in cystic fibrosis patientsFri, 17 Dec 2010, 13:03:57 EST
- Mucus: Fighting the war against pollutantsWed, 30 Mar 2011, 10:04:30 EDT
- Cystic fibrosis treatments may have unseen long-term benefitsThu, 16 Jul 2009, 10:51:40 EDT